Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure.
Ceccherini-Silberstein, Francesca; Erba, Fulvio; Gago, Federico; Bertoli, Ada; Forbici, Federica; Bellocchi, Maria Concetta; Gori, Caterina; D'Arrigo, Roberta; Marcon, Luisa; Balotta, Claudia; Antinori, Andrea; Monforte, Antonella D'Arminio; Perno, Carlo-Federico.
; 18(12): F11-9, 2004 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-15280771
The role of backward mutations on the within-host dynamics of HIV-1.
Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics.
Estimation of the HIV-1 backward mutation rate from transmitted drug-resistant strains.
Prevalence of HIV-1 Drug Resistance among Patients with Antiretroviral Therapy Failure in Sichuan, China, 2010-2016.
The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.
Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.
Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Treatment-naïve Patients in Korea: a Prospective, Observational Study.
Antiretroviral resistance in HIV-1 patients at a tertiary medical institute in Saudi Arabia: a retrospective study and analysis.
Geneticheskoe raznoobrazie virusov immunodefitsita cheloveka i antiretrovirusnaya terapiya.
[Indicators of the human immunodeficiency virus drug resistance to antiretroviral drugs in HIV-infected individuals in the Siberian Federal District in 2010-2012].